BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2004
View Archived Issues
New glycogen phosphorylase inhibitors discovered at Yamanouchi
Read More
New DPP-IV inhibitors prepared and tested by Sanwa Kagaku scientists
Read More
Kissei presents new SGLT-1 inhibitors for diabetes and related disorders
Read More
Novel GnRH antagonists in early development at Takeda
Read More
Chugai claims new vitamin D analogues and their use in calcium metabolism disorders
Read More
Takeda researchers discover new agonists of the bile acid-responsive receptor TGR5
Read More
Novel oligoadenylic acid derivatives for use in cancer and viral infections
Read More
Novel steryl sulfatase inhibitors discovered at Kyowa Hakko
Read More
Bicifadine enters acute pain phase III trial
Read More
Third indication studied for SGN-30 in new phase II trial
Read More
New phase I study evaluates RG-1068 for obsessive-compulsive disorder
Read More
Acambis receives fast track status for MVA program
Read More
Glenmark and Forest collaborate on GRC-3886
Read More
Phase IIa study of BXL-628 for BPH meets primary endpoint
Read More
Takeda submits NDA for ramelteon for insomnia
Read More
Dosing commences in study of controlled-release oral RSD-1235
Read More
Enrollment open in phase I study of AQ4N
Read More
Non-approvable letter for oral tazarotene
Read More
FDA Advisory Committee to review Marqibo in December
Read More
Adalimumab promotes clinical remission in moderate to severe Crohn's disease
Read More
FibroGen licenses FG-2216 to Yamanouchi for Japan
Read More
Update on the efficacy of cilansetron in diarrhea-predominant IBS
Read More
Y-40138 protective in hepatitis models
Read More
ECO-4601 shown to cross blood-brain barrier
Read More
Canadian approval for phase I trial of Occlusin
Read More
Reduced GI tract mucosal injury seen with AZD-3582
Read More
DA-6034 safe but poorly absorbed in healthy subjects
Read More
BPC-157 lessens effects of alcohol intoxication and withdrawal
Read More
PTK-787/ZK-222584 enhances antitumor activity of NVP-LAQ-824
Read More
COX inhibition, antiinflammatory action of imrecoxib described
Read More
Inhibition of Hsp90 in the treatment of SCLC
Read More
ZD-4054 specifically inhibits ETA receptor-mediated antiapoptotic events
Read More